(Q37162738)

English

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study

scientific article published on 19 June 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Daniel W Coyne

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Dennis L Andress

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael J Amdahl

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Eberhard Ritz

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Dick de Zeeuw

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

19 June 2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

28

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

2260-2268

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

6 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Use of vitamin D in chronic kidney disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Association of oral calcitriol with improved survival in nondialyzed CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Hyperphosphatemia of chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Immulite 2000 parathyroid hormone assay: stability of parathyroid hormone in EDTA blood kept at room temperature for 48 h.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT227

21 January 2018

Vitamin D levels and patient outcome in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT227

21 January 2018

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation, CRP, calcium overload and a high calcium-phosphate product: a "liaison dangereuse"

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose calcitriol versus placebo in patients with predialysis chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone markers predict cardiovascular events in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NDT/GFT227

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37162738&oldid=1864587471"